INTERCEPT PHARMACEUTICALS, INC. (38) | Bonus & Incentive Agreements (4)
- 2022 Cash Incentive Plan (Filed With SEC on January 31, 2022)
- 2022 Cash Incentive Plan - Form of Performance-Based Award Agreement (Filed With SEC on January 31, 2022)
- Form of Performance Stock Unit Grant Notice and Agreement (Filed With SEC on February 25, 2020)
- Form of Performance Stock Unit Grant Notice and Agreement (Filed With SEC on May 8, 2019)
